Huahai Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zhejiang Huahai Pharmaceutical Co Ltd (600521)
Zhejiang Huahai Pharmaceutical Co Ltd stock price live, this page displays SS 600521 stock exchange data. View the 600521 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zhejiang Huahai Pharmaceutical Co Ltd real time stock price chart below.
What Is the Zhejiang Huahai Pharmaceutical Co Ltd Stock Price Today?
The Zhejiang Huahai Pharmaceutical Co Ltd stock price today is 17.61.
What Is the Stock Symbol for Zhejiang Huahai Pharmaceutical Co Ltd?
The stock symbol for Zhejiang Huahai Pharmaceutical Co Ltd is "600521."
What Stock Exchange Does Zhejiang Huahai Pharmaceutical Co Ltd Trade On?
Zhejiang Huahai Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is Zhejiang Huahai Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Zhejiang Huahai Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600521 quote. (ISIN: CNE000001DL5)
What Is the Zhejiang Huahai Pharmaceutical Co Ltd Stock Price Today?
The Zhejiang Huahai Pharmaceutical Co Ltd stock price today is 17.61.
What Is the Stock Symbol for Zhejiang Huahai Pharmaceutical Co Ltd?
The stock symbol for Zhejiang Huahai Pharmaceutical Co Ltd is "600521."
What Stock Exchange Does Zhejiang Huahai Pharmaceutical Co Ltd Trade On?
Zhejiang Huahai Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is Zhejiang Huahai Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Zhejiang Huahai Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600521 quote. (ISIN: CNE000001DL5)
Shanghai
Currency in CNY
17.61
-0.26(-1.45%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.43
17.90
52 wk Range
13.73
19.14
600521 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.4317.90
52 wk Range
13.7319.14
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600521 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
18.83
Upside
+6.95%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
2 Buy
0 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 18.83
(+6.95% Upside)
Earnings
Latest Release
Oct 30, 2026
EPS / Forecast
0.18 / 0.14
Revenue / Forecast
2.11B / 1.97B
Compare 600521 to Peers and Sector
Metrics to compare | 600521 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600521PeersSector | |
|---|---|---|---|---|
P/E Ratio | 27.7x | 17.6x | −0.2x | |
PEG Ratio | 0.29 | 0.12 | 0.00 | |
Price/Book | 2.6x | 2.1x | 2.6x | |
Price / LTM Sales | 2.7x | 2.6x | 2.8x | |
Upside (Analyst Target) | 6.9% | 25.3% | 65.6% | |
Fair Value Upside | Unlock | 24.2% | 10.0% | Unlock |
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production, and sales of generic drugs, biologics, drugs, and specialty active pharmaceutical ingredients in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Zhejiang Huahai Pharmaceutical (600521) Stock Price Today?
The Zhejiang Huahai Pharmaceutical stock price today is 17.61 CNY.
What Stock Exchange Does Zhejiang Huahai Pharmaceutical Trade On?
Zhejiang Huahai Pharmaceutical is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Zhejiang Huahai Pharmaceutical?
The stock symbol for Zhejiang Huahai Pharmaceutical is "600521."
Does Zhejiang Huahai Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?
The Zhejiang Huahai Pharmaceutical dividend yield is 0.6%%.
What Is the Zhejiang Huahai Pharmaceutical Market Cap?
As of today, Zhejiang Huahai Pharmaceutical market cap is 26.24B CNY.
What Is Zhejiang Huahai Pharmaceutical's Earnings Per Share (TTM)?
The Zhejiang Huahai Pharmaceutical EPS (TTM) is 0.63.
When Is the Next Zhejiang Huahai Pharmaceutical Earnings Date?
Zhejiang Huahai Pharmaceutical will release its next earnings report on Apr 27, 2027.
From a Technical Analysis Perspective, Is 600521 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Zhejiang Huahai Pharmaceutical Stock Split?
Zhejiang Huahai Pharmaceutical has split 10 times.
How Many Employees Does Zhejiang Huahai Pharmaceutical Have?
Zhejiang Huahai Pharmaceutical has 8797 employees.
What is the current trading status of Zhejiang Huahai Pharmaceutical (600521)?
As of Nov 07, 2026, Zhejiang Huahai Pharmaceutical (600521) is trading at a price of 17.61 CNY, with a previous close of 17.87 CNY. The stock has fluctuated within a day range of 17.43 CNY to 17.90 CNY, while its 52-week range spans from 13.73 CNY to 19.14 CNY.
What Is Zhejiang Huahai Pharmaceutical (600521) Price Target According to Analysts?
The average 12-month price target for Zhejiang Huahai Pharmaceutical is 18.83 CNY, with a high estimate of 21.5 CNY and a low estimate of 14 CNY. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +6.95% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.